Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

April 26, 2022

Study Completion Date

April 30, 2023

Conditions
Stroke, AcuteThromboses, Intracranial
Interventions
DRUG

Tenecteplase

Stroke Thrombolytic

DRUG

Alteplase

Stroke Thrombolytic

Trial Locations (22)

T2N2T9

University of Calgary, Calgary

Unknown

Grey Nuns Hospital, Edmonton

University of Alberta, Edmonton

Medicine Hat Regional Hospital, Medicine Hat

Red Deer Regional Hospital, Red Deer

Kelowna General Hospital, Kelowna

Royal Columbian Hospital, New Westminster

Vancouver General Hospital, Vancouver

University of Manitoba, Winnipeg

Halifax Infirmary Queen Elizabeth II, Halifax

Hamilton Health Sciences General Hospital, Hamilton

Kingston Health Science Centre, Kingston

London Health Sciences, London

Ottawa Civic Hospital, Ottawa

St. Michaels Hospital, Toronto

Sunnybrook Health Sciences Centre, Toronto

Toronto Western Hospital, Toronto

Queen Elizabeth Hospital, Charlottetown

CHUM -Centre Hospitalier de l'Universite de Montreal, Montreal

Univerisite Laval-Hopital de l'Enfant-Jesus, Québec

Universite de Sherbrooke, Sherbrooke

Royal University Hospital, Saskatoon

All Listed Sponsors
lead

University of Calgary

OTHER

NCT03889249 - Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter